The nuclear medicine global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Nuclear Medicine Market, 2024 report by The Business Research Company offers
comprehensive insights into the current state of the market and highlights
future growth opportunities.
Market Size -
The nuclear medicine market size has grown rapidly in recent years. It will
grow from $7.75 billion in 2023 to
$8.88 billion in 2024 at a compound
annual growth rate (CAGR) of 14.6%.
The growth in the historic period
can be attributed to aging population, cancer diagnosis and staging, cardiology
applications, neurological disorders, regulatory approvals.
The nuclear medicine market size is expected to see rapid growth in the next
few years. It will grow to $14.1 billion
in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be
attributed to personalized medicine, oncology and neurology research,
sustainable practices, research and development, telemedicine services. Major
trends in the forecast period include radioimmunotherapy, hybrid imaging,
artificial intelligence (ai), emerging radiopharmaceuticals, diagnostic imaging
advancements.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Scope Of Nuclear Medicine Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Nuclear Medicine Market Overview
Market Drivers -
The increase in constancy and prevalence of cardiovascular disease (CVD) and
cancer are expected to propel the growth of the nuclear medicine market going
forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel
disorders, and cancer is a disease in which cells grow out of control and
spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac
diseases more quickly. Nuclear medicine therapy is a method to treat cancer
that might be used with or after other therapy options, such as surgery and
chemotherapy. As a result, the growing constancy and prevalence of
cardiovascular disease and cancer increases the demand for nuclear medicine
market. For instance, in January 2023, according to the American Cancer Society
Inc., a US-based non-profit health group, in 2023, 1,958,310 new cancer cases
are expected to be diagnosed in the US, an increase compared to more than
1,918,030 new cancer cases in 2022.
Therefore, the growing constancy and prevalence of cardiovascular
diseases and cancer are driving the nuclear medicine market.
The nuclear medicine market covered in this report is segmented –
1) By Type: Diagnostic, Therapeutic
2) By Application: Cardiology, Lymphomia, Thyroid, Neurology, Oncology, Other
Application
3) By End-User: Hospitals and Clinics, Diagnostic Centers, Other End Users
Get an inside scoop of the nuclear medicine market, Request now for Sample
Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp
Regional Insights -
North America was the largest region in the nuclear medicine market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the nuclear medicine market report include
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East and Africa.
Key Companies -
Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical
Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant
Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal
Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced
Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements,
Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge
Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc.,
FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic
Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals
Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc.,
Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics
Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC
Isotope Inc., NorthStar Medical Radioisotopes LLC
Table of Contents
1. Executive Summary
2. Nuclear Medicine Market Report Structure
3. Nuclear Medicine Market Trends And Strategies
4. Nuclear Medicine Market – Macro Economic Scenario
5. Nuclear Medicine Market Size And Growth
…..
27. Nuclear Medicine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment